Bridgefront Capital’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-616
Closed -$101K 511
2024
Q2
$101K Buy
616
+69
+13% +$9.83K 0.04% 449
2024
Q1
$83.4K Buy
+547
New +$91K 0.06% 353
2022
Q2
Sell
-334
Closed -$212K 291
2022
Q1
$212K Buy
+334
New +$172K 0.26% 197

Other funds holding AGL

Bridgefront Capital's AGL Position: Q3 2024 in Review

Bridgefront Capital sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 616 shares — an estimated $101K sold.

Bridgefront Capital first reported a position in AGL in Q1 2022 and held it in 3 quarters. The position peaked at $212K in Q1 2022. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • Bridgefront Capital reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • Bridgefront Capital sold 616 Agilon Health shares in Q3 2024, an estimated $101K.
  • Bridgefront Capital first reported a position in Agilon Health in Q1 2022 and held it in 3 quarters.
  • Bridgefront Capital's Agilon Health position peaked at $212K in Q1 2022.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Bridgefront Capital's 13F filing for Q3 2024, filed 14 Nov 2024.